Sara Sjölin's profile photo

Sara Sjölin

Copenhagen

Copenhagen Bureau Chief at Bloomberg News

Bloomberg Copenhagen Bureau Chief. Stock market enthusiast. Formerly reporter at @MarketWatch and Berlingske. Tweets are my own views - RTs not an endorsement.

Articles

  • 2 weeks ago | financialpost.com | Christian Wienberg |William Mathis |Sara Sjölin

    Advertisement 1Denmark, a global leader in wind power, spent five months licking its wounds after a failed auction for offshore turbines delivered a blow to expand even further. Article content(Bloomberg) — Denmark, a global leader in wind power, spent five months licking its wounds after a failed auction for offshore turbines delivered a blow to expand even further. Sign In or Create an AccountArticle contentWe apologize, but this video has failed to load.

  • 2 weeks ago | bloomberg.com | Christian Wienberg |William Mathis |Sara Sjölin

    Offshore wind turbines at the Middelgrunden wind farm off the coast of Copenhagen, Denmark. (Bloomberg) -- Denmark, a global leader in wind power, spent five months licking its wounds after a failed auction for offshore turbines delivered a blow to expand even further. The government is so set on protecting the industry that it’s now offering developers huge subsidies for new wind farms.

  • 2 weeks ago | bloomberg.com | Christian Wienberg |Sara Sjölin

    The Novo Nordisk A/S pharmaceutical manufacturing facility in Hillerod. (Bloomberg) -- Denmark’s economy shrank in the first quarter, dragged down by lower drug sales, underscoring the Nordic nation’s increased dependency on its large pharmaceutical sector, which is led by Novo Nordisk A/S. Gross domestic product adjusted for seasonal swings fell 0.5% last quarter compared with the previous three-month period, the worst performance since late 2022, Statistics Denmark said on Tuesday.

  • 3 weeks ago | news.bloombergtax.com | Christian Wienberg |Sara Sjölin

    Novo Nordisk A/S’s surprise decision to replace Chief Executive Officer Lars Fruergaard Jorgensen has triggered a race to fill a role that is almost never available: the winner will be only its fourth leader since 1981. The Danish pharma giant hasn’t immediately lined up an internal candidate and said it has started a search. After some prominent recent departures, it may look externally.

  • 3 weeks ago | news.bloomberglaw.com | Christian Wienberg |Sara Sjölin

    Novo Nordisk A/S’s surprise decision to replace Chief Executive Officer Lars Fruergaard Jorgensen has triggered a race to fill a role that is almost never available: the winner will be only its fourth leader since 1981. The Danish pharma giant hasn’t immediately lined up an internal candidate and said it has started a search. After some prominent recent departures, it may look externally.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
5K
Tweets
4K
DMs Open
No
Sara Sjölin
Sara Sjölin @sarasjolin
5 Mar 25

With a just a week until the Greenland election, Trump has repeated his push to take control of the island. Greenlanders decisively reject the idea of becoming American, but Trump's overture has nevertheless shaken up campaigning for the March 11 vote. https://t.co/leech7uq8U

Sara Sjölin
Sara Sjölin @sarasjolin
7 Nov 24

RT @ZSchneeweiss: Trump sounds ready to stay engaged in Europe, Danish Prime Minister Mette Frederiksen says https://t.co/tiwWkjZfgR via @s…

Sara Sjölin
Sara Sjölin @sarasjolin
7 Aug 24

Novo Nordisk just released earnings - misses profit estimate, but sees sales rise 25%. * NOVO 2Q WEGOVY SALES DKK11.66B, EST. DKK13.66B